Bioventus (BVS) Change in Working Capital (2020 - 2022)
Bioventus posted quarterly Change in Working Capital of $1.1 million for Q2 2022, down 87.62% year-on-year from $9.2 million in Q2 2021, and up 59.27% on a QoQ basis from $712000.0 in Q4 2021.
Bioventus (BVS) has 3 years of Change in Working Capital data on file, last reported at $1.1 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -46.83 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 2, 2022 | 1.13 Mn |
| Apr 2, 2022 | 1.13 Mn |
| Oct 2, 2021 | 712,000.00 |
| Oct 2, 2021 | 712,000.00 |
| Jul 3, 2021 | 3.85 Mn |
| Jul 3, 2021 | 3.85 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Mar 28, 2020 | -369,000.00 |
| Mar 28, 2020 | -369,000.00 |